A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2

Barden Chan, Shengfang Jin(Agios Pharmaceuticals (United States)), Marion Dorsch(Biogen (United States)), Gromoslaw A. Smolen(Celsius Therapeutics (United States)), Zhi‐Zhong Lin(Xiamen University), Gavin Histen(Agios Pharmaceuticals (United States)), Yuanfeng Xia(WuXi AppTec (China)), Shinsan M. Su(Agios Pharmaceuticals (United States)), Lee Silverman(Agios Pharmaceuticals (United States)), Ryan Thompson(ID Genomics (United States)), Chris Singleton(Agios Pharmaceuticals (United States)), Michelle Clasquin(Agios Pharmaceuticals (United States)), Yong Cang(ShanghaiTech University), Chenming Lu(WuXi AppTec (China)), Yan Liu(First Hospital of China Medical University), Yue Chen(Agios Pharmaceuticals (United States)), Zhonghua Yan(Takeda (United States)), Josh Powe(Agios Pharmaceuticals (United States)), Hudson H. Freeze(Discovery Institute)
Human Molecular Genetics
April 5, 2016
Cited by 47


Related Papers